Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Acq. announced
Quarterly results

PTC THERAPEUTICS, INC. (PTCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/17/2023 4 Gravier Pierre (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 26,000 shares @ $0
Granted 65,000 options to buy @ $39.82, valued at $2.6M
07/17/2023 3 Gravier Pierre (CFO) has filed a Form 3 on PTC THERAPEUTICS, INC.
06/09/2023 4 SCHMERTZLER MICHAEL (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 1,000 shares @ $44.86, valued at $44.9k
06/07/2023 4 Bell William F. Jr. (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Granted 4,000 shares @ $0
Granted 2,333 shares @ $0
Granted 10,000 options to buy @ $45.015, valued at $450.2k
Granted 5,834 options to buy @ $45.015, valued at $262.6k
06/07/2023 3 Bell William F. Jr. (Director) has filed a Form 3 on PTC THERAPEUTICS, INC.
05/24/2023 4 Reeve Emma (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 173 shares @ $59.5242, valued at $10.3k
Sold 2,995 shares @ $59.5335, valued at $178.3k
Sold 3,948 shares @ $59.5313, valued at $235k
Sold 157 shares @ $59.5171, valued at $9.3k
Sold 1,093 shares @ $59.532, valued at $65.1k
Sold 1,402 shares @ $59.5378, valued at $83.5k
Exercised 173 options to buy @ $33.63, valued at $5.8k
Exercised 2,995 options to buy @ $33.02, valued at $98.9k
Exercised 3,948 options to buy @ $33.63, valued at $132.8k
Exercised 157 options to buy @ $33.63, valued at $5.3k
Exercised 1,093 options to buy @ $33.02, valued at $36.1k
05/23/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 6,403 shares @ $58.9553, valued at $377.5k
Sold 1,913 shares @ $58.9783, valued at $112.8k
Sold 100 shares @ $59.66, valued at $6k
05/19/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 800 shares @ $58.5175, valued at $46.8k
Sold 7,248 shares @ $58.5, valued at $424k
Sold 788 shares @ $58.7143, valued at $46.3k
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 SOUTHWELL DAVID P (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 2,571 shares @ $50.0476, valued at $128.7k
Exercised 2,571 options to buy @ $18.01, valued at $46.3k
03/31/2023 4 Utter Christine Marie (SVP, FINANCE & CAO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 3,247 shares @ $47.798, valued at $155.2k
Sold 1,441 shares @ $47.7752, valued at $68.8k
Exercised 4,688 options to buy @ $40.45, valued at $189.6k
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Utter Christine Marie (SVP, FINANCE & CAO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 325 shares @ $45.628, valued at $14.8k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 375 shares @ $45.628, valued at $17.1k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2023 4 Peltz Stuart Walter (CEO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 284 shares @ $47.4513, valued at $13.5k
01/26/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 359 shares @ $47.4513, valued at $17k
01/26/2023 4 Hill Emily Luisa (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 223 shares @ $47.4513, valued at $10.6k
01/26/2023 4 Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 44 shares @ $47.4513, valued at $2.1k
01/12/2023 4 Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 473 shares @ $42.9329, valued at $20.3k
Sold 27 shares @ $42.9329, valued at $1.2k
Sold 383 shares @ $44.3596, valued at $17k
Sold 27 shares @ $44.3596, valued at $1.2k
01/12/2023 4 Boulding Mark Elliott (EXEC. VP AND CLO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 590 shares @ $42.9329, valued at $25.3k
Sold 495 shares @ $44.3596, valued at $22k
01/12/2023 4 Hill Emily Luisa (CFO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 497 shares @ $42.9329, valued at $21.3k
Sold 418 shares @ $44.3596, valued at $18.5k
01/12/2023 4 Klein Matthew B. (COO) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 2,273 shares @ $42.9329, valued at $97.6k
Sold 2,244 shares @ $44.3596, valued at $99.5k
01/12/2023 4 Pauwels Eric (CHIEF BUSINESS OFFICER) has filed a Form 4 on PTC THERAPEUTICS, INC.
Txns: Sold 663 shares @ $42.9329, valued at $28.5k
Sold 571 shares @ $44.3596, valued at $25.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy